Efficacy and safety of ustekinumab in East Asian patients with moderately to severely active ulcerative colitis: a subpopulation analysis of global phase 3 induction and maintenance studies (UNIFI)

Efficacy and safety of ustekinumab in East Asian patients with moderately to severely active ulcerative colitis: a subpopulation analysis of global phase 3 induction and maintenance studies (UNIFI)

Background/Aims We aimed to evaluate the efficacy and safety of ustekinumab (UST) in the East-Asian population with moderate to severely active ulcerative colitis (UC). Methods This sub-analysis was conducted on data from East-Asian patients included in the UNIFI program (NCT02407236). UNIFI consist...

Full description

Bibliographic Details
Main Authors: Tadakazu Hisamatsu, Hyo Jong Kim, Satoshi Motoya, Yasuo Suzuki, Yoshifumi Ohnishi, Noriyuki Fujii, Nobuko Matsushima, Richuan Zheng, Colleen W. Marano
Format: Article
Language:English
Published: Korean Association for the Study of Intestinal Diseases 2021-10-01
Series:Intestinal Research
Subjects:
east-asian
ulcerative colitis
subgroup analysis
unifi
ustekinumab
Online Access:http://www.irjournal.org/upload/pdf/ir-2020-00080.pdf

Internet

http://www.irjournal.org/upload/pdf/ir-2020-00080.pdf

Similar Items